Clinical evaluation of nebulized verapamil in out-patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.

Publication Year: 2022

DOI:
10.1111/crj.13551

PMCID:
PMC9716709

PMID:
36336743

Journal Information

Full Title: Clin Respir J

Abbreviation: Clin Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST There is no conflict of interest to declare. The financial support of the study was offered by Shahid Beheshti University of Medical Sciences, and all authors' financial support given in order to complete the study or write the manuscript."

Evidence found in paper:

"Funding information Shahid Beheshti University of Medical Sciences"

Evidence found in paper:

"This study was a double‐blind randomized placebo‐controlled clinical trial (RCT), registered at the Australian New Zealand Clinical Trials Registry, which can be accessed via www.anzctr.org.au (registration number: ACTRN12612001239853)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025